You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
諾輝健康旗下幽幽管全網首發 72小時限時優惠價139元
格隆匯1月18日丨諾輝健康(6606.HK)旗下幽門螺桿菌消費者自測產品幽幽管今日首發!凌晨已全面上線京東、愛康、美團買藥、天貓、平安健康、樂薦幾大電商平台。目前幽幽管僅在大陸地區銷售,海外市場暫時無法供貨。自18日首發當日0點至21日8:59:59,所有發售平台將為每支幽幽管補貼10元,限時優惠價139元。2022年1月21日9點起,幽幽管恢復市場零售指導價149元。自18日起,諾輝健康聯合京東健康將為幽幽管用户推出一站式線上就醫問診、用藥治療、複查全流程服務。用户可通過諾輝健康訂閲號或聯繫諾輝健康線上客服,一鍵接通京東健康極速問診,實現13萬全國公立醫院醫生在線服務,極速問診平均回覆時間2分鐘以內,65%的在線醫生為三甲醫院。幽幽管於2022年1月6日獲得國家藥品監督管理局(NMPA)批准的三類醫療器械註冊申請。這是國家藥監局批准的中國首個適用於“消費者自測”的幽門螺桿菌檢測產品。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account